Short-latency afferent inhibition and somato-sensory evoked potentials during the migraine cycle: surrogate markers of a cycling cholinergic thalamo-cortical drive?

by Gianluca Coppola, Davide Di Lenola, Chiara Abagnale, Fabio Ferrandes, Gabriele Sebastianelli, Francesco Casillo, Cherubino Di Lorenzo, Mariano Serrao, Maurizio Evangelista, Jean Schoenen, Francesco Pierelli
Published 2020-04-01

Use of outpatient medical care by headache patients in Germany: a population-based cross-sectional study

by Britta Müller, Thomas Dresler, Charly Gaul, Tim Jürgens, Peter Kropp, Anna Rehfeld, Olaf Reis, Ruth Ruscheweyh, Andreas Straube, Stefanie Förderreuther
Published 2020-05-01

Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence

by Alejandro Labastida-Ramírez, Silvia Benemei, Maria Albanese, Antonina D’Amico, Giovanni Grillo, Oxana Grosu, Devrimsel Harika Ertem, Jasper Mecklenburg, Elena Petrovna Fedorova, Pavel Řehulka, Francesca Schiano di Cola, Javier Trigo Lopez, Nina Vashchenko, Antoinette MaassenVanDenBrink, Paolo Martelletti, On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Published 2020-05-01

Spreading depression as a preclinical model of migraine

by Andrea M. Harriott, Tsubasa Takizawa, David Y. Chung, Shih-Pin Chen
Published 2019-05-01

Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care

by Minna A. Korolainen, Samu Kurki, Mariann I. Lassenius, Iiro Toppila, Madlaina Costa-Scharplatz, Timo Purmonen, Markku Nissilä
Published 2019-02-01

The cerebellum is associated with 2-year prognosis in patients with high-frequency migraine

by Hung-Yu Liu, Pei-Lin Lee, Kun-Hsien Chou, Kuan-Lin Lai, Yen-Feng Wang, Shih-Pin Chen, Wei-Ta Chen, Shuu-Jiun Wang
Published 2020-03-01

CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?

by Valentina Favoni, Luca Giani, Linda Al-Hassany, Gian Maria Asioli, Calogera Butera, Irene de Boer, Martina Guglielmetti, Chrysoula Koniari, Theodoros Mavridis, Marge Vaikjärv, Iris Verhagen, Angela Verzina, Bart Zick, Paolo Martelletti, Simona Sacco, European Headache Federation School of Advanced Studies (EHF-SAS)
Published 2019-03-01

Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVO...

by Jessica Ailani, J. Scott Andrews, Mallikarjuna Rettiganti, Robert A. Nicholson
Published 2020-10-01

Hypoechogenicity of brainstem raphe correlates with depression in migraine patients

by Wei-Wei Tao, Xin-Ting Cai, Jie Shen, Xue-Gong Shi, Yu Wang
Published 2019-05-01

Migraine, headache, and mortality in women: a cohort study

by Jessica L. Rohmann, Pamela M. Rist, Julie E. Buring, Tobias Kurth
Published 2020-03-01

Clinical characteristics of nummular headache and differentiation between spontaneous and posttraumatic variant: an observational study

by Javier Trigo, David García-Azorín, Enrique Martinez Pias, Álvaro Sierra, Alba Chavarría, Angel Luis Guerrero
Published 2019-04-01

Correction to: Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison study

by Casper Emil Christensen, Samaira Younis, Ulrich Lindberg, Vincent Oltman Boer, Patrick de Koning, Esben Thade Petersen, Olaf Bjarne Paulson, Henrik Bo Wiberg Larsson, Faisal Mohammad Amin, Messoud Ashina
Published 2019-05-01

Aura and Stroke: relationship and what we have learnt from preclinical models

by Muge Yemisci, Katharina Eikermann-Haerter
Published 2019-05-01

Migraine and episodic Vertigo: a cohort survey study of their relationship

by Christian Lampl, Alan Rapoport, Moris Levin, Elisabeth Bräutigam
Published 2019-04-01

The impact of remission and coexisting migraine on anxiety and depression in cluster headache

by Byung-Su Kim, Pil-Wook Chung, Byung-Kun Kim, Mi Ji Lee, Jeong Wook Park, Min Kyung Chu, Jin-Young Ahn, Dae Woong Bae, Tae-Jin Song, Jong-Hee Sohn, Kyungmi Oh, Daeyoung Kim, Jae-Moon Kim, Soo-Kyoung Kim, Yun-Ju Choi, Jae Myun Chung, Heui-Soo Moon, Chin-Sang Chung, Kwang-Yeol Park, Soo-Jin Cho
Published 2020-05-01

Optimising migraine treatment: from drug-drug interactions to personalized medicine

by Leda Marina Pomes, Martina Guglielmetti, Enrico Bertamino, Maurizio Simmaco, Marina Borro, Paolo Martelletti
Published 2019-05-01

The burden of headache disorders in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease study 2016

by Kia Vosoughi, Lars Jacob Stovner, Timothy J. Steiner, Maziar Moradi-Lakeh, Seyed-Mohammad Fereshtehnejad, Farshad Farzadfar, Pouria Heydarpour, Reza Malekzadeh, Mohsen Naghavi, Mohammad Ali Sahraian, Sadaf G. Sepanlou, Arash Tehrani-Banihashemi, Reza Majdzadeh, Valery L. Feigin, Theo Vos, Ali H. Mokdad, Christopher J. L. Murray
Published 2019-04-01

Headache medication and the COVID-19 pandemic

by Antoinette MaassenVanDenBrink, Tessa de Vries, A. H. Jan Danser
Published 2020-04-01

Aids to management of headache disorders in primary care (2nd edition)

by T. J. Steiner, R. Jensen, Z. Katsarava, M. Linde, E. A. MacGregor, V. Osipova, K. Paemeleire, J. Olesen, M. Peters, P. Martelletti
Published 2019-05-01

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

by Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas, Paolo Martelletti
Published 2019-05-01